Bryan Alexander Profile
Bryan Alexander

@Bryan_IDPharmD

Followers
662
Following
4K
Media
48
Statuses
944

Infectious Disease, ASP, and OPAT Pharmacist at Nebraska Medicine @UNMC_ID

Omaha, NE
Joined October 2018
Don't wanna be here? Send us removal request.
@Bryan_IDPharmD
Bryan Alexander
4 months
RT @bryan_p_white: Our new paper on vancomycin AUC dosing in obesity is out. Rates of AKI were lower in the AUC group compared to the troug….
0
8
0
@Bryan_IDPharmD
Bryan Alexander
9 months
RT @unmccscash: We’re excited to celebrate the #PowerOfRural on #NationalRuralHealthDay! Join us in recognizing the spirit of #rural Americ….
0
3
0
@Bryan_IDPharmD
Bryan Alexander
10 months
RT @IDWeekmtg: .@UnmcCop student Gabe Codling has 60 SECONDS to explain his poster on doxyPEP usage. 😅 #IDWeek2024
0
12
0
@Bryan_IDPharmD
Bryan Alexander
10 months
0
5
0
@Bryan_IDPharmD
Bryan Alexander
10 months
RT @JonathanRyderMD: Using this data, we built a local genotypic antibiogram. This informs our ASP recommendations for which agents to use….
0
2
0
@Bryan_IDPharmD
Bryan Alexander
11 months
RT @Darcy_ID_doc: Soooo excited to hear @LauraMarks5 talking about the intersection of IDU and Staph aureus. @WashUID . 🥳🥳woot woot 🥳🥳. She….
0
7
0
@Bryan_IDPharmD
Bryan Alexander
1 year
RT @MatiH_ID: Thank you Nebraska ID Society and @UNMC_ID for inviting me to keynote at your annual meeting. Loved discussing the intersecti….
0
7
0
@Bryan_IDPharmD
Bryan Alexander
1 year
RT @IDstewardship: 🚨 Help us make a list! What are your fav educational OPAT resources for patients or providers? 🙏. #IDtwitterx #TwitteRx….
0
13
0
@Bryan_IDPharmD
Bryan Alexander
1 year
RT @SaratoninSyndrm: 🔥Hot off the press!🔥. ➡️Results of a national survey of OPATs describing their AMS practices! Programs may use the res….
Tweet card summary image
academic.oup.com
This cross-sectional survey describes the antimicrobial stewardship (AMS) practices currently employed by outpatient parenteral antimicrobial therapy (OPAT
0
16
0
@Bryan_IDPharmD
Bryan Alexander
1 year
Excited to finally see a large-scale registry trial that shows no difference for no ABX cement in primary TKA. NNT = many hundreds! Definitely still some confounding and heterogeneity in a huge registry trial like this, but unlikely to get a RCT here. Can Ortho be convinced? 👀🙂.
@ABsteward
Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟
1 year
🆕️🔥Cohort study that has the largest international registry-based meta-analysis performed to date.@JAMANetworkOpen.The risk of revision for PJI was similar between antibiotic-loaded bone cement and plain bone cement following primary TKA. #idxposts .
0
4
19
@Bryan_IDPharmD
Bryan Alexander
1 year
RT @bergmanscott: Congrats to all the graduates! I am proud to coordinate a terrific team of ID pharmacists @unmc_ID who were voted APPE pr….
0
7
0
@Bryan_IDPharmD
Bryan Alexander
1 year
RT @bergmanscott: At SHEA last year, many saw/commented on our poster about increased cefazolin prescribing after suppression of non-severe….
Tweet card summary image
cambridge.org
Perioperative cefazolin prescribing rates following suppression of alerts for non-IgE-mediated penicillin allergies - Volume 45 Issue 9
0
13
0
@Bryan_IDPharmD
Bryan Alexander
1 year
RT @accpinfdprn: This survey describes the AMS practices currently employed by OPAT programs across the US. Institutions may reference th….
0
5
0
@Bryan_IDPharmD
Bryan Alexander
1 year
RT @kcmolinaID: Dalbavancin non-inferior to SOC in complicated SAB. Big spoiler for the highly anticipated DOTS trial. Can't wait to see th….
0
21
0
@Bryan_IDPharmD
Bryan Alexander
1 year
RT @JonathanRyderMD: 1/ This week in #IDTwitter @dralicehan asked a great question about meropenem-resistant Strep pneumo. @UNMC_ID ASP r….
0
56
0
@Bryan_IDPharmD
Bryan Alexander
1 year
RT @OFIDJournal: A Critical Need: More Data on Antimicrobial Stewardship Programs in Critical Access Hospitals. ✅ Just Accepted.🔓 Open Acce….
0
6
0
@Bryan_IDPharmD
Bryan Alexander
1 year
RT @JeremyTigh: Wonderful start to the Iowa Antimicrobial Stewardship Summit learning about CDC efforts! @CDC_AR @JonathanRyderMD @bergmans….
0
5
0